Ceritinib in Combination With Stereotactic Ablative Radiation Metastatic Lung Adenocarcinoma
Clinical trial NCT02513667 · TERMINATED
Trial details
- NCT number
- NCT02513667
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2020-05-29
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.